Literature DB >> 23873282

Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia.

Kazuhisa Chonabayashi1, Masakatsu Hishizawa, Masashi Matsui, Tadakazu Kondo, Tatsuharu Ohno, Takayuki Ishikawa, Akifumi Takaori-Kondo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873282     DOI: 10.1007/s00277-013-1843-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant.

Authors:  L Falchi; M Mehrotra; K J Newberry; L M Lyle; G Lu; K P Patel; R Luthra; U Popat; S Verstovsek
Journal:  Leukemia       Date:  2014-05-23       Impact factor: 11.528

Review 2.  Eosinophilia in Hematologic Disorders.

Authors:  Lorenzo Falchi; Srdan Verstovsek
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

3.  ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML.

Authors:  Barbara Spitzer; Filemon S Dela Cruz; Glorymar D Ibanez Sanchez; Yanming Zhang; Wenbin Xiao; Ryma Benayed; Alina Markova; M Irene Rodriguez-Sanchez; Nancy Bouvier; Mikhail Roshal; Andrew L Kung; Neerav Shukla
Journal:  Blood Adv       Date:  2021-04-13

Review 4.  Updates on eosinophilic disorders.

Authors:  Alexandar Tzankov; Kaaren K Reichard; Robert P Hasserjian; Daniel A Arber; Attilio Orazi; Sa A Wang
Journal:  Virchows Arch       Date:  2022-09-07       Impact factor: 4.535

5.  A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?

Authors:  E Troadec; S Dobbelstein; P Bertrand; N Faumont; F Trimoreau; M Touati; J Chauzeix; B Petit; D Bordessoule; J Feuillard; C Bastard; N Gachard
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528

6.  ETV6/FLT3 Fusion Is a Novel Client Protein of Hsp90.

Authors:  Bui Thi Kim Ly; Hoang Thanh Chi
Journal:  Oncol Res       Date:  2018-02-22       Impact factor: 5.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.